Community/Retail

The FDA has added a new warning to the drug label of the methylphenidate transdermal system indicated for ADHD to describe permanent loss of skin color, also known as chemical leukoderma.

Three leading pharmacy organizations have asked the FDA to help avoid any potential disruptions in the pharmaceutical supply chain by delaying enforcement of a July 1 product tracing deadline.

An increasing number of adults receiving prescription stimulant medications challenge the notion that ADHD is a children's condition and create new obstacles for pharmacists.

Distributing naloxone kits through pharmacies, public health departments, and other community-based channels has bolstered opioid overdose prevention in the last 5 years.

Otsuka Pharmaceutical Co., Ltd. has entered into a partnership with the government of Saitama Prefecture with the aim of promoting health and wellbeing among prefectural citizens.

The American Medical Association commends the U.S. House of Representatives on its vote to repeal the Independent Payment Advisory Board (IPAB) policy.

Lester Nathan, The Pharmacy Sage, discusses the future of independent pharmacy.

Pharmacists can play an important role in counseling patients on the common symptoms of MERS.

A battery-powered device that allows blind patients to "see" with their tongues has been cleared by the FDA.

The American Lung Association and Pfizer today announced the launch of Quitter's Circle, a mobile app and online community designed to help smokers face common obstacles.

The University of Cincinnati Board of Trustees today approved renaming the Health Professions Building on the medical campus as Joseph F. Kowalewski Hall in honor of the former dean of the university's pharmacy school.

Biogen announced today that it has achieved carbon neutrality, a milestone reached through a multi-year initiative to reduce its own emissions and by investing in environmental projects.

Negative perceptions of facial redness affect rosacea patients' social, emotional, and psychological wellbeing.

Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.

Cellphone bans can improve test scores for students who struggle in school.

John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio discusses the components of successful transitions of care programs.

The FDA has issued a Class I recall for the HeartWare Ventricular Assist System (VAS), citing malfunction in the device's electrical connection that could cause serious patient injury or death.

Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx explains how physician-pharmacist collaboration can result in improved patient care.

Deanna Bauerlein, a student at the Philadelphia College of Pharmacy, discusses the most important issues affecting pharmacists.

Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx offers tips for pharmacists looking for inclusion in an ACO/PCMH model.

On Father's Day, I spent the majority of my waking hours working in the pharmacy, because I know my patients need me to be there.

Pharmacists can reassure patients taking pre-exposure prophylaxis that the human immunodeficiency virus prevention treatment will not increase their risk for depression.

Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx explains the important of provider status in value-based care.

Developed by the National Association of Chain Drug Stores (NACDS), a webinar series will provide the roadmap to success for retailers and suppliers in lead-up to the 2015 NACDS Total Store Expo.

The FDA today approved Medtronic's recapturable and self-expanding CoreValve Evolut R System for transcatheter aortic valve replacement.

Deanna Bauerlein, a student at the Philadelphia College of Pharmacy, discusses the most rewarding experiences from pharmacy school.

High hospital readmission rates plague the health care system.

Pfizer Inc. today announced that it has entered into an agreement with GlaxoSmithKline to acquire its quadrivalent meningitis ACWY vaccines for a total consideration of approximately $130 million.